These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12187692)

  • 21. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
    Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Graft-v-host disease following blood transfusions.
    Weiden P
    Arch Intern Med; 1984 Aug; 144(8):1557-8. PubMed ID: 6466011
    [No Abstract]   [Full Text] [Related]  

  • 24. Who requires irradiated blood products?
    Challis M; Marrin C; Vaughan RS; Goringe A
    Anaesthesia; 2011 Jul; 66(7):620-1. PubMed ID: 21682701
    [No Abstract]   [Full Text] [Related]  

  • 25. Gamma-irradiation of blood products following autologous stem cell transplantation: surveillance of the policy of 35 centers.
    Weiss B; Hoffmann M; Anders C; Hellstern P; Schmitz N; Uppenkamp M;
    Ann Hematol; 2004 Jan; 83(1):44-9. PubMed ID: 14551741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretransfusion blood irradiation: clinical rationale and dosimetric considerations.
    Masterson ME; Febo R
    Med Phys; 1992; 19(3):649-57. PubMed ID: 1508104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfusion-associated graft-versus-host disease.
    Rappeport JM
    Yale J Biol Med; 1990; 63(5):445-54. PubMed ID: 2293503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevention of post-transfusion graft versus host disease by irradiating blood products with X-ray or gamma-ray].
    Tanaka S
    Nihon Rinsho; 1997 Sep; 55(9):2277-81. PubMed ID: 9301290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfusion associated graft versus host disease.
    Anwar M; Bhatti FA
    J Ayub Med Coll Abbottabad; 2003; 15(3):56-8. PubMed ID: 14727344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abrogation or exacerbation of graft-versus-host disease by transfusing hematopoietic stem cell donors with recipient-specific blood.
    Muirhead DY
    Transplant Proc; 1988 Dec; 20(6):1090-1. PubMed ID: 2904714
    [No Abstract]   [Full Text] [Related]  

  • 31. [Posttransfusion graft vs host disease].
    Muñoz MC; Hernández M; Rifón J; Panizo C; Rodríguez M
    Sangre (Barc); 1998 Feb; 43(1):55-8. PubMed ID: 9580428
    [No Abstract]   [Full Text] [Related]  

  • 32. [Institution and significance of the new guidelines for prevention of transfusion associated graft versus host disease].
    Asai T
    Nihon Rinsho; 1997 Sep; 55(9):2296-304. PubMed ID: 9301293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Transfusion-associated graft-versus-host disease].
    Chen Z
    Zhonghua Nei Ke Za Zhi; 1997 May; 36(5):291-2. PubMed ID: 10374266
    [No Abstract]   [Full Text] [Related]  

  • 34. Transfusion-associated graft-versus-host disease.
    Ohmori K; Sato H; Furukawa H; Sagara H; Kanno M
    Fukushima J Med Sci; 1993 Dec; 39(2):89-94. PubMed ID: 7927139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective conditioning for acute graft-versus-host disease.
    Ayala E; Kharfan-Dabaja M
    N Engl J Med; 2005 Dec; 353(25):2718; author reply 2718. PubMed ID: 16371641
    [No Abstract]   [Full Text] [Related]  

  • 36. [Blood transfusion and transplantation].
    Ishikura H; Endo J
    Rinsho Byori; 1991 Jul; Suppl 90():139-50. PubMed ID: 1920850
    [No Abstract]   [Full Text] [Related]  

  • 37. Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease.
    Ho VT; Kim HT; Li S; Hochberg EP; Cutler C; Lee SJ; Fisher DC; Milford E; Kao G; Daley H; Levin J; Ng A; Mauch P; Alyea EP; Antin JH; Soiffer RJ
    Bone Marrow Transplant; 2004 Dec; 34(11):987-94. PubMed ID: 15489873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Graft-versus-host disease.
    Kodo H
    Nihon Ketsueki Gakkai Zasshi; 1987 Dec; 50(8):1621-6. PubMed ID: 2833846
    [No Abstract]   [Full Text] [Related]  

  • 39. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
    Gaziev J; Sodani P; Polchi P; Andreani M; Lucarelli G
    Ann N Y Acad Sci; 2005; 1054():196-205. PubMed ID: 16339666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Post-transfusion graft-vs-host disease].
    Ito K
    Nihon Naika Gakkai Zasshi; 1999 Mar; 88(3):532-6. PubMed ID: 10341636
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.